banner add

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

from NYT > Health https://ift.tt/HO1FV4S
via IFTTT

No comments

Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’

The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the inte...

Theme images by PLAINVIEW. Powered by Blogger.